Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: A double-blind, randomized, placebo-controlled trial

European Neurology

Volumn 69, Issue 5, 2013, Pages 309-316

  Mortazavi, Mojgan ^a   Moeinzadeh, Firouzeh ^a   Saadatnia, Mohammad ^b,c,e   Shahidi, Shahrzad ^a   McGee, Jeanie C ^d   Minagar, Alireza ^d  

^a Isfahan Kidney Disease Research Center   (Taiwan)

^b Isfahan Neurosciences Research Center   (Taiwan)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Louisiana State University Health Sciences Center at Shreveport   (United States)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Carotid intima media thickness; Flow mediated dilatation; Hemodialysis; Magnesium supplementation

Indexed keywords

ALBUMIN; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM OXIDE; PHOSPHATE; PHOSPHORUS; TRIACYLGLYCEROL; CALCIUM ION; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PLACEBO;

ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CALCIUM BLOOD LEVEL; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; FLOW MEDIATED DILATATION; HEMODIALYSIS PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; ADULT; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; DIARRHEA; DRUG EFFICACY; DRUG WITHDRAWAL; FOLLOW UP; HEMODIALYSIS; MAGNESIUM BLOOD LEVEL; MINERAL SUPPLEMENTATION; MULTICENTER STUDY; PROTEIN BLOOD LEVEL; STUDY; TREATMENT DURATION;

ADULT; AGED; ANALYSIS OF VARIANCE; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; DILATATION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MAGNESIUM; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS;

EID: 84875670083     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000346427     Document Type: Article

References (44)

1. Collins AJ, Foley RN, Herzog C, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers PW, Agodoa L: Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010; 55:S1-S7.
2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119. (Pubitemid 28527268)
3. Vanholder R, Meert N, Schepers E, Glorieux G, Argiles A, Brunet P: Review on uraemic solutes II-variability in reported concentrations: causes and consequences. Nephrol Dial Transplant 2007; 22: 3115-3121. (Pubitemid 350202539)
4. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S: Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8: 54-58. (Pubitemid 38508656)
5. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
6. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441.
7. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
8. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
9. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138. (Pubitemid 32880350)
10. Ennever J, Vogel JJ: Magnesium inhibition of apatite nucleation by proteolipid. J Dent Res 1981; 60: 838-841.
11. Wei M, Esbaei K, Bargman J, Oreopoulos DG: Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease? Int Urol Nephrol 2006; 38: 317-322. (Pubitemid 44138160)
12. Wei M, Esbaei K, Bargman JM, Oreopoulos DG: Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int 2006; 26: 366-373. (Pubitemid 44340006)
13. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-940.
14. Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998; 136: 480-490. (Pubitemid 28413547)
15. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432-1437. (Pubitemid 27375333)
16. Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefyllakis N, et al: Intra-and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 2004; 17: 102-108. (Pubitemid 39107244)
17. Lindeman RD: Chronic renal failure and magnesium metabolism. Magnesium 1986; 5: 293-300.
18. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ: Assessment of flow mediated dilation (FMD) in humans: a methodological and technical guideline. Am J Physiol Heart Circ Physiol 2011; 300:H2-H12.
19. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519-14522.
20. Ghiadoni L, Versari D, Giannarelli C, Faita F, Taddei S: Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 2008; 14: 3715-3722.
21. Devaraj S, Singh U, Jialal I: The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009; 55: 229-238.
22. Fabbian F, Cacici G, Franceschini L, Russo G, Vassanelli C, Catizone L, Lupo A: The relationship between carotid and coronary atherosclerotic damage in dialysis patients. Int J Artif Organs 2007; 30: 315-320. (Pubitemid 46938856)
23. Maier JA: Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med 2003; 24: 137-146. (Pubitemid 36092147)
24. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-940.
25. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A: Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008; 40: 1075-1082.
26. Baldassarre D, De JA, Amato M, Werba JP, Castelnuovo S, Frigerio B, Veglia F, Tremoli E, Sirtori CR: Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med 2008; 40: 21-44. (Pubitemid 351197923)
27. Montecucco F, Mach F: New evidences for Creactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin Interv Aging 2008; 3: 341-349. (Pubitemid 352037872)
28. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y: Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56. (Pubitemid 46201802)
29. Nishizawa Y, Shoji T, Kawagishi T, Morii H: Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int Suppl 1997; 62:S90-S92. (Pubitemid 27489414)
30. Wei M, Esbaei K, Bargman J, Oreopoulos DG: Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int 2006; 26: 366-373. (Pubitemid 44340006)
31. Meema HE, Oreopoulos DG, Rapoport A: Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 1987; 32: 388-394. (Pubitemid 17147886)
32. Ouchi Y, Tabata RE, Stergiopoulos K, Sato F, Hattori A, Orimo H: Effect of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. Arteriosclerosis 1990; 10: 732-737. (Pubitemid 20273346)
33. Orimo H, Ouchi Y: The role of calcium and magnesium in the development of atherosclerosis. Experimental and clinical evidence. Ann NY Acad Sci 1990; 598: 444-457.
34. Altura BT, Brust M, Bloom S, Barbour RL, Stempak JG, Altura BM: Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci USA 1990; 87: 1840-1844.
35. Neglen P, Qvarfordt P, Eklof B: Peroral magnesium hydroxide therapy and intermittent claudication-a preliminary report. Vasa 1985; 14: 285-288. (Pubitemid 15009128)
36. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H: Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003; 92: 665-669. (Pubitemid 37103015)
37. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y: Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56. (Pubitemid 46201802)
38. Malpuech-Brugere C, Nowacki W, Gueux E, Kuryszko J, Rock E, Rayssiguier Y, Mazur A: Accelerated thymus involution in magnesium-deficient rats is related to enhanced apoptosis and sensitivity to oxidative stress. Br J Nutr 1999; 81: 405-411. (Pubitemid 29292161)
39. Touyz RM: Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 2003; 24: 107-136. (Pubitemid 36096860)
40. Rukshin V, Azarbal B, Shah PK, Tsang VT, Shechter M, Finkelstein A, Cercek B, Kaul S: Intravenous magnesium in experimental stent thrombosis in swine. Arterioscler Thromb Vasc Biol 2001; 21: 1544-1549. (Pubitemid 34219822)
41. Altura BM, Altura BT, Gebrewold A, et al: Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 1984; 223: 1315-1317. (Pubitemid 14163190)
42. Boskey AL, Posner AS: Effect of magnesium on lipid-induced calcification: an in vitro model for bone mineralization. Calcif Tissue Int 1980; 32: 139-143. (Pubitemid 11234463)
43. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J: Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 1999; 34: 43-48. (Pubitemid 29318794)
44. Navarro-Gonzalez JF: Magnesium in dialysis patients: serum levels and clinical implications. Clin Nephrol 1998; 49: 373-378. (Pubitemid 28271469)